Exemestane Powder
Quick details:
Product Name : Exemestane, Aromasin Powder
CAS : 107868-30-4
Molecular Formula : C20H24O2
Molecular Weight : 296.4
Purity : 99%
Appearance : White powder
Physical Form : Solid
Melting Point : 155.13A A C
Storage Temp : Room Temperature
Half Life : 24 Hours
Common Doses : 12.5mg per day
Detection Time : 2 Weeks
Drug Class : Oral Anti-Estrogen
Exemestane Powder Show:

Description
Exemestane, chemical name 6-methyleneandrosta-1,4-diene-3,17-dione, trade name Aromasin, is a third-generation aromatase inhibitor developed by Pharmacia & Upjoin of Italy. It was first approved for marketing in the UK in April 1999, and has been launched in the United States, Germany, Switzerland, Canada and Nordic countries. It is mainly used in the treatment of advanced breast cancer in postmenopausal women. Its mechanism of action is irreversible binding to the substrate binding site of aromatase, inactivating aromatase and thus reducing the level of estrogen in plasma. Exemestane has a strong and specific aromatase inhibitory effect. As a second-line and third-line treatment for postmenopausal women with estrogen-dependent breast cancer, it is superior to standard therapy in terms of tumor shrinkage, prolonged survival rate and disease stability rate, with few adverse reactions, showing good application prospects.
Pharmacological action
The growth of breast cancer cells can depend on the presence of estrogen. The estrogen (estrone and estradiol) in the circulation of postmenopausal women is mainly converted by aromatase in peripheral tissues from androgens (androstenedione and testosterone) in the adrenal glands and ovaries. Preventing estrogen production by inhibiting aromatase is an effective selective treatment for postmenopausal hormone-dependent breast cancer. Exemestane is an irreversible steroid aromatase inactivator. It is structurally similar to androstenedione, the natural substrate of the enzyme, and is a pseudo-substrate of aromatase. It can inactivate the enzyme by irreversibly binding to its active site, thereby significantly reducing the level of estrogen in the blood circulation of postmenopausal women, but has no significant effect on the biosynthesis of corticosteroids and aldosterone in the adrenal glands. At a concentration 600 times higher than the aromatase inhibitory concentration, it has no significant effect on other enzymes in the steroidogenesis pathway.
The growth of breast cancer cells can depend on the presence of estrogen. The estrogen (estrone and estradiol) in the circulation of postmenopausal women is mainly converted from androgens (androstenedione and testosterone) in the adrenal glands and ovaries by aromatase in peripheral tissues. Preventing estrogen production by inhibiting aromatase is an effective and selective method for treating postmenopausal hormone-dependent breast cancer. Exemestane is an irreversible steroidal aromatase inactivator. It is similar in structure to the natural substrate of the enzyme, androstenedione, and is a pseudo-substrate of aromatase. It can inactivate the enzyme by irreversibly binding to its active site, thereby significantly reducing the level of estrogen in the blood circulation of postmenopausal women, but has no significant effect on the biosynthesis of corticosteroids and aldosterone in the adrenal glands. At a concentration 600 times higher than the concentration that inhibits aromatase, it has no significant effect on other enzymes in the steroidogenesis pathway.
Indications and Usage:
EXEMESTANE is an aromatase inhibitor indicated for:
adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to EXEMESTANE for completion of a total of five consecutive years of adjuvant hormonal therapy.
This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Exemestane is also used to help prevent the cancer from coming back. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps slow or reverse the growth of these breast cancers.
Dosage and Administration:
Recommended Dose: One 25 mg tablet once daily after a meal.
Hot Tags: exemestane powder, China exemestane powder manufacturers, suppliers, factory, Fareston, Toremifene Citrate Raw Powder, Arimidex, Anti Estrogen PCT, Toremifene Citrate, Tamoxifen Citrate












